Header Logo

Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.

Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours. Eur J Cancer. 2019 10; 120:132-139.

View in: PubMed